Post Profile

Related Posts

AstraZeneca plc (ADR) (AZN): Is This Purchase a Game-Changer?

Business & Finance / Investing : Insider Monkey

London-based pharmaceutical giant AstraZeneca plc (ADR) (NYSE:AZN) recently announced that it had agreed to purchase U.S.-based lung-drug manufacturer Pearl Therapeutics for at least $1.1 billion. The private firm is noted for its n...

GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): The Good and Bad of a Competitor’s Failure

Business & Finance / Investing : Insider Monkey

On the surface, GlaxoSmithKline plc (ADR) (NYSE:GSK)‘s release of phase 2 data on drisapersen looks like good news for Sarepta Therapeutics Inc (NASDAQ:SRPT)‘s competing Duchenne Muscular Dystrophy drug, eteplirsen. Investors seem t...

GlaxoSmithKline plc (ADR) (GSK), Gilead Sciences, Inc. (GILD): Did Sarepta Therapeutics Inc (SRPT) Just Knock Out Its DMD Competitor?

Business & Finance / Investing : Insider Monkey

Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa  for a moment, because these are exciting times for the roughly 1 in 4,000 newborns worldwide who...

AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): A Big Pharma Company With a Juicy Dividend Yield and Low Valuation

Business & Finance / Investing : Insider Monkey

Recently, AstraZeneca plc (ADR) (NYSE:AZN) announced that it has agreed to acquire Pearl Therapeutics, the respiratory drug manufacturer, in a transaction worth around $1.15 billion. Since the beginning of the year, AstraZeneca plc ...

Is Adaptimmune Therapeutics PLC – ADR (ADAP) A Good Stock To Buy?


Copyright © 2016 Regator, LLC